Blue Ridge Bankshares (BRBS) Q1 EPS Of US$0.01 Tests Premium 25.8x P/E Narrative

Blue Ridge Bankshares, Inc.

Blue Ridge Bankshares, Inc.

BRBS

0.00

Blue Ridge Bankshares (BRBS) opened 2026 with Q1 total revenue of US$19.9 million and basic EPS of roughly US$0.01, setting a measured tone for the new year after a period of mixed results. Over recent quarters the company has seen revenue move from US$22.1 million in Q1 2025 to US$23.8 million in Q2, US$27.5 million in Q3 and US$22.3 million in Q4, while basic EPS has ranged from a Q1 2025 loss of about US$0.01 per share to profits of US$0.01 to US$0.06 in the subsequent periods. This now feeds into trailing twelve month EPS of about US$0.14. That backdrop provides an earnings and revenue base investors can use to judge whether current margins look sustainable or more like a fragile reset.

See our full analysis for Blue Ridge Bankshares.

With the latest figures on the table, the next step is to set these margins and earnings against the stories investors already tell about Blue Ridge Bankshares to see which narratives still hold up and which start to look stretched.

NYSEAM:BRBS Earnings & Revenue History as at Apr 2026
NYSEAM:BRBS Earnings & Revenue History as at Apr 2026

Profitable Year, But Q1 Net Income Softens

  • Net income excluding extra items was US$0.8 million in Q1 2026, compared with US$4.2 million in Q4 2025 and trailing twelve month net income of US$12.0 million, so the latest quarter sits well below the recent annual run rate.
  • What stands out for a cautiously bullish view is that trailing twelve month EPS of US$0.14 and net income of US$12.0 million follow earlier loss making periods, even though the single quarter Q1 2026 EPS of roughly US$0.01 and net income of US$0.8 million highlight that profitability is still relatively thin.
    • Earlier quarters in the trailing set included losses, such as a trailing twelve month net loss of US$15.4 million in Q4 2024. In that context, the latest US$12.0 million profit marks a clear shift in the reported figures.
    • At the same time, the five year earnings trend shows a 42.7% annual decline. This means the recent profitability sits against a longer record of earnings pressure that bullish investors need to keep in view.

Loan Quality Metrics Show Mixed Signals

  • Non performing loans were US$25.4 million in Q4 2024 and moved within a band of roughly US$23.8 million to US$28.6 million through 2025, while the allowance for bad loans sits at 82%, which is flagged as low because it is below 100% coverage.
  • Critics focusing on a bearish angle point to the 82% allowance for bad loans and the five year 42.7% annual earnings decline as pressure points, and the data partially supports that concern because non performing loans have remained in the US$20 million to US$30 million range while earnings have only recently turned positive.
    • Trailing twelve month profitability of US$12.0 million and EPS of US$0.14 indicate that losses are not present in the latest year, which limits the extent to which credit issues have flowed through into fresh annual losses.
    • However, with non performing loans not shown moving materially lower in the provided figures and a loan loss allowance below 100%, the cautious view that credit costs could weigh on future results is firmly grounded in the current disclosures.
On a cautious view of credit and earnings quality, some investors will want a deeper breakdown of how bears frame the risk side of the story before deciding how much weight to put on Q1’s softer net income. 🐻 Blue Ridge Bankshares Bear Case

Premium 25.8x P/E Against Banks Peers

  • BRBS trades on a trailing P/E of 25.8x, compared with 11.7x for the US Banks industry and 14.3x for its peer group, so the shares change hands at a materially higher multiple despite the five year 42.7% annual earnings decline in the background.
  • What is interesting for investors weighing a more optimistic read is that the recent move back to profitability, with trailing twelve month EPS at US$0.14 on a share price of US$3.58, sits alongside this premium 25.8x P/E. This means the market is assigning richer terms while the long term earnings trend in the data still points to a multi year decline.
    • Trailing twelve month revenue of US$93.5 million is modestly below the US$95.7 million and US$96.8 million levels seen in earlier trailing periods, so the higher P/E multiple is not matched by a clear step up in the revenue base in the figures provided.
    • The combination of a premium P/E, earnings that only recently turned positive, and an 82% bad loan allowance gives investors a compact checklist of numbers to track when deciding whether the current valuation multiple feels justified.
If you want to see how other investors connect this premium P/E, the recent return to profitability, and the loan quality data into a single storyline, it is worth reading through the broader community narrative for extra context. Curious how numbers become stories that shape markets? Explore Community Narratives

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Blue Ridge Bankshares's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

The mix of improving profits, loan risks, and a premium P/E can feel like a lot to weigh. Take a moment to review the numbers, stress test your own thesis, and then check the 1 key reward and 2 important warning signs.

See What Else Is Out There

Blue Ridge Bankshares currently combines thin profitability, an 82% bad loan allowance below full coverage, and a premium 25.8x P/E that sits above peers.

If you are uneasy about paying up for a bank with tight margins and credit questions, compare it with companies in the 72 resilient stocks with low risk scores that score better on resilience and downside protection.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.